CYST WALL ENDOPROTEASES OF ENTAMOEBA INVADENS AND ENTAMOEBA HISTOLYTICA
入侵内阿米巴和溶组织内阿米巴的囊壁内切蛋白酶
基本信息
- 批准号:7955937
- 负责人:
- 金额:$ 0.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alpha-mannosidaseAmebic colitisAnabolismAnti-Retroviral AgentsBiochemicalBiologyComplexComputer Retrieval of Information on Scientific Projects DatabaseConcanavalin ACyanovirin-NCystEndoplasmic ReticulumEntamoeba histolyticaEntamoeba invadensFundingGlucosyltransferaseGlucosyltransferasesGlycoproteinsGrantInstitutionLectinLinkLiver AbscessMass Spectrum AnalysisMedicineMethodsPolysaccharidesQuality ControlResearchResearch PersonnelResourcesSourceSurfaceSystemUnited States National Institutes of HealthUpper arminterestprotein foldingsugar nucleotide
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
N-Glycans of Entamoeba histolytica, the protist that causes amebic dysentery and liver abscess, are of great interest for multiple reasons. E. histolytica makes an unusual truncated N-glycan precursor (Man(5)GlcNAc(2)), has few nucleotide sugar transporters, and has a surface that is capped by the lectin concanavalin A. Here, biochemical and mass spectrometric methods were used to examine N-glycan biosynthesis and the final N-glycans of E. histolytica with the following conclusions. Unprocessed Man(5)GlcNAc(2), which is the most abundant E. histolytica N-glycan, is aggregated into caps on the surface of E. histolytica by the N-glycan-specific, anti-retroviral lectin cyanovirin-N. Glc(1)Man(5)GlcNAc(2), which is made by a UDP-Glc: glycoprotein glucosyltransferase that is part of a conserved N-glycan-dependent endoplasmic reticulum quality control system for protein folding, is also present in mature N-glycans. A swainsonine-sensitive alpha-mannosidase trims some N-glycans to biantennary Man(3)GlcNAc(2). Complex N-glycans of E. histolytica are made by the addition of alpha1,2-linked Gal to both arms of small oligomannose glycans, and Gal residues are capped by one or more Glc. In summary, E. histolytica N-glycans include unprocessed Man(5)GlcNAc(2), which is a target for cyanovirin-N, as well as unique, complex N-glycans containing Gal and Glc.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
溶组织内阿米巴是引起阿米巴痢疾和肝脓肿的原生生物,其N-糖链引起人们的极大兴趣,原因有很多。溶组乳杆菌产生一种不寻常的截短的N-糖前体(Man(5)GlcNAc(2)),几乎没有核苷酸糖转运体,其表面被刀豆蛋白A所覆盖。未加工的人(5)GlcNAc(2)是最丰富的N-糖链,通过N-糖特异性的抗逆转录病毒凝集素氰病毒素-N聚集在组织链球菌胞外膜上。GLC(1)Man(5)GlcNAc(2)是由UDP-GLC:糖蛋白葡萄糖转移酶产生的,它是保守的N-糖依赖的内质网蛋白质折叠质量控制系统的一部分,也存在于成熟的N-糖中。苦马豆素敏感的α-甘露糖苷酶将一些N-糖链修剪成双天线的Man(3)GlcNAc(2)。溶组埃希菌的复杂N-糖链是通过在小分子寡聚糖的两个臂上添加α-1,2-连接的半乳糖而形成的,半乳糖残基由一个或多个糖链封端。总之,溶解组织杆菌的N-聚糖包括未加工的Man(5)GlcNAc(2),它是氰基韦林-N的靶标,以及含有Gal和GLC的独特的复杂N-聚糖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John C. Samuelson其他文献
Novel antibodies detect nucleocytoplasmic O-fucose in protist pathogens, cellular slime molds, and plants
新型抗体检测原生生物病原体、细胞黏菌和植物中的核质 O-岩藻糖
- DOI:
10.1128/msphere.00945-24 - 发表时间:
2025-02-03 - 期刊:
- 影响因子:3.100
- 作者:
Megna Tiwari;Elisabet Gas-Pascual;Manish Goyal;Marla Popov;Kenjiroo Matsumoto;Marianne Grafe;Ralph Gräf;Robert S. Haltiwanger;Neil Olszewski;Ron Orlando;John C. Samuelson;Christopher M. West - 通讯作者:
Christopher M. West
John C. Samuelson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John C. Samuelson', 18)}}的其他基金
The Biochemistry and Cell Biology of the SpindlyO-fucosyltransferase of Toxoplasma
弓形虫 SpindlyO-岩藻糖基转移酶的生物化学和细胞生物学
- 批准号:
10541113 - 财政年份:2020
- 资助金额:
$ 0.47万 - 项目类别:
The Biochemistry and Cell Biology of the SpindlyO-fucosyltransferase of Toxoplasma
弓形虫 SpindlyO-岩藻糖基转移酶的生物化学和细胞生物学
- 批准号:
10300056 - 财政年份:2020
- 资助金额:
$ 0.47万 - 项目类别:
The Biochemistry and Cell Biology of the Spindly O-fucosyltransferase of Toxoplasma
弓形虫纺锤体O-岩藻糖基转移酶的生物化学和细胞生物学
- 批准号:
9897291 - 财政年份:2020
- 资助金额:
$ 0.47万 - 项目类别:
Genetic modification of cultured Cryptosporidium to test the autoinfection model
对培养的隐孢子虫进行基因改造以测试自身感染模型
- 批准号:
9305341 - 财政年份:2017
- 资助金额:
$ 0.47万 - 项目类别:
Structure and Development of Oocyst and Sporocyst Walls
卵囊和孢子囊壁的结构和发育
- 批准号:
9206440 - 财政年份:2015
- 资助金额:
$ 0.47万 - 项目类别:
CYST WALL ENDOPROTEASES AND GLYCANS OF PARASITES
寄生虫的囊壁内切蛋白酶和聚糖
- 批准号:
8365537 - 财政年份:2011
- 资助金额:
$ 0.47万 - 项目类别:
CYST WALL ENDOPROTEASES AND GLYCANS OF PARASITES
寄生虫的囊壁内切蛋白酶和聚糖
- 批准号:
8170905 - 财政年份:2010
- 资助金额:
$ 0.47万 - 项目类别:
CYST WALL ENDOPROTEASES OF ENTAMOEBA INVADENS AND ENTAMOEBA HISTOLYTICA
入侵内阿米巴和溶组织内阿米巴的囊壁内切蛋白酶
- 批准号:
7723041 - 财政年份:2008
- 资助金额:
$ 0.47万 - 项目类别:
CYST WALL ENDOPROTEASES OF ENTAMOEBA INVADENS AND ENTAMOEBA HISTOLYTICA
入侵内阿米巴和溶组织内阿米巴的囊壁内切蛋白酶
- 批准号:
7602035 - 财政年份:2007
- 资助金额:
$ 0.47万 - 项目类别:
CYST WALL ENDOPROTEASES OF ENTAMOEBA INVADENS AND ENTAMOEBA HISTOLYTICA
入侵内阿米巴和溶组织内阿米巴的囊壁内切蛋白酶
- 批准号:
7369317 - 财政年份:2006
- 资助金额:
$ 0.47万 - 项目类别:
相似海外基金
Cooperative Research Partnership for an Amebic Colitis Vaccine
阿米巴结肠炎疫苗合作研究伙伴关系
- 批准号:
8068078 - 财政年份:2010
- 资助金额:
$ 0.47万 - 项目类别:
Cooperative Research Partnership for an Amebic Colitis Vaccine
阿米巴结肠炎疫苗合作研究伙伴关系
- 批准号:
7882490 - 财政年份:2006
- 资助金额:
$ 0.47万 - 项目类别:
Cooperative Research Partnership for an Amebic Colitis Vaccine
阿米巴结肠炎疫苗合作研究伙伴关系
- 批准号:
7667916 - 财政年份:2006
- 资助金额:
$ 0.47万 - 项目类别:
Cooperative Research Partnership for an Amebic Colitis Vaccine
阿米巴结肠炎疫苗合作研究伙伴关系
- 批准号:
7134936 - 财政年份:2006
- 资助金额:
$ 0.47万 - 项目类别:
Cooperative Research Partnership for an Amebic Colitis Vaccine
阿米巴结肠炎疫苗合作研究伙伴关系
- 批准号:
7254053 - 财政年份:2006
- 资助金额:
$ 0.47万 - 项目类别:
Cooperative Research Partnership for an Amebic Colitis Vaccine
阿米巴结肠炎疫苗合作研究伙伴关系
- 批准号:
7480269 - 财政年份:2006
- 资助金额:
$ 0.47万 - 项目类别:
Mucosal immune regulation in murine amebic colitis
小鼠阿米巴结肠炎的粘膜免疫调节
- 批准号:
7065631 - 财政年份:2003
- 资助金额:
$ 0.47万 - 项目类别:
Mucosal immune regulation in murine amebic colitis
小鼠阿米巴结肠炎的粘膜免疫调节
- 批准号:
7233217 - 财政年份:2003
- 资助金额:
$ 0.47万 - 项目类别:
Mucosal immune regulation in murine amebic colitis
小鼠阿米巴结肠炎的粘膜免疫调节
- 批准号:
6762351 - 财政年份:2003
- 资助金额:
$ 0.47万 - 项目类别:
Mucosal immune regulation in murine amebic colitis
小鼠阿米巴结肠炎的粘膜免疫调节
- 批准号:
6876172 - 财政年份:2003
- 资助金额:
$ 0.47万 - 项目类别:














{{item.name}}会员




